Symposium: Translational Development of Diverse Drug Formulations

Moderator(s)

• 

  Shanghao Li, PhD

  Associate Director, DMPK
  WuXi AppTec
  Cranbury

Presentations:

• 9:00 AM - 9:30 AM CT

  Harnessing In Vitro Models for NAMs-Based Inhalable Substance Safety Assessments
  

  Speaker: Erin A. Huber, PhD (she/her/hers) – RTI International
• 9:30 AM - 10:00 AM CT

  Oral Peptide Drug Development: Addressing Preclinical Bioavailability and PK Challenges
  

  Speaker: Jianping Sun (he/him/his) – WuXi AppTec
• 10:00 AM - 10:30 AM CT

  In-Vitro Tools to Streamline Subcutaneous Drug Development
  

  Speaker: Mikhail Murashov, PhD (he/him/his) – Merck & Co., Inc.
• 10:30 AM - 11:00 AM CT

  Predicting Human Subcutaneous Bioavailability of Monoclonal Antibodies Using an Integrated In-Vitro/In-Silico Approach
  

  Speaker: Jenna Caldwell, PhD – AstraZeneca